Bellevue Group’s Adaptive Biotechnologies ADPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.06M	Sell	76,181 -221,909	-74%	-$3.54M	0.03%	90
2025 Q4	$4.84M	Buy	298,090 +129,614	+77%	+$2.12M	0.09%	77
2025 Q3	$2.52M	Buy	+168,476	New	+$2.05M	0.05%	93
2023 Q1	–	Sell	-2,960,131	Closed	-$22.6M	–	162
2022 Q4	$22.6M	Sell	2,960,131 -319,489	-10%	-$2.49M	0.3%	78
2022 Q3	$23.4M	Sell	3,279,620 -259,435	-7%	-$2.44M	0.34%	77
2022 Q2	$28.6M	Buy	3,539,055 +393,762	+13%	+$3.46M	0.4%	67
2022 Q1	$43.7M	Buy	3,145,293 +1,176,862	+60%	+$18.5M	0.51%	62
2021 Q4	$55.2M	Buy	1,968,431 +632,408	+47%	+$19.4M	0.57%	59
2021 Q3	$45.4M	Buy	1,336,023 +373,671	+39%	+$13.5M	0.46%	68
2021 Q2	$39.3M	Buy	+962,352	New	+$37.4M	0.38%	80